![Eran Perry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eran Perry
Direktör/Styrelseledamot på
COMPUGEN LTD.
Förmögenhet: 44 800 $ per 2026-08-31
Profil
Mr. Eran Perry is a Co-Founder and Board Member at Upstream Bio, Inc., a Co-Managing Director at Maruho Israel Innovation Fund and a Co-Founder at ICD Pharma Ltd. He is on the Board of Directors at Upstream Bio, Inc. and Compugen Ltd.
Mr. Perry was previously employed as a Board Member by Musli Thyropeutics Ltd., a Partner by I.H.C.V Israel Healthcare Ventures Ltd., an Associate by Mckinsey & Co. /Israel/, and a Business Analyst by Novartis AG /U.S.
Biologics Manufacturing Operation/.
He received his MBA from Columbia Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
COMPUGEN LTD. 0,02 % | 2026-07-29 | 17 500 ( 0,02 % ) | 44 800 $ | 2026-08-31 |
Aktiva positioner av Eran Perry
| Företag | Position | Start |
|---|---|---|
| COMPUGEN LTD. | Direktör/Styrelseledamot | 2019-07-01 |
Maruho Israel Innovation Fund
 Maruho Israel Innovation Fund Financial ConglomeratesFinance Provides investment services in dermatology-related technologies | Verkställande Direktör | 2018-01-01 |
ICD Pharma Ltd.
 ICD Pharma Ltd. Pharmaceuticals: OtherHealth Technology Operates as a clinical-stage pharmaceutical company that develops cannabis-based therapies for use as medical cannabis products | Grundare | 2017-04-01 |
Novartis Oncology | Försäljning & Marknadsföring | - |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Direktör/Styrelseledamot | - |
Noon Aesthetics Ltd.
 Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Manufactures skin care products | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Eran Perry
| Företag | Position | Slut |
|---|---|---|
| UPSTREAM BIO, INC. | Grundare | 2023-06-01 |
Musli Thyropeutics Ltd.
 Musli Thyropeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for cancer treatment | Direktör/Styrelseledamot | 2021-08-01 |
I.H.C.V Israel Healthcare Ventures Ltd.
 I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures invests in companies located in the Israel. The firm targets companies operating in the fields of medical devices, biotechnology, pharmaceuticals and health IT. It provides financing for early stage capital requirements. | Privat kapitalinvesterare | 2016-09-01 |
| ░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Eran Perrys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
85
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
I.H.C.V Israel Healthcare Ventures Ltd.
I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures invests in companies located in the Israel. The firm targets companies operating in the fields of medical devices, biotechnology, pharmaceuticals and health IT. It provides financing for early stage capital requirements. | Finance |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG /U.S. Biologics Manufacturing Operation/
 Novartis AG /U.S. Biologics Manufacturing Operation/ Pharmaceuticals: MajorHealth Technology Manufactures Bayer's Betaseron, a pharmaceutical product | Health Technology |
Mckinsey & Co. /Israel/ | Commercial Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Health Technology |
Musli Thyropeutics Ltd.
Musli Thyropeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for cancer treatment | Health Technology |
Maruho Israel Innovation Fund
Maruho Israel Innovation Fund Financial ConglomeratesFinance Provides investment services in dermatology-related technologies | Finance |
ICD Pharma Ltd.
ICD Pharma Ltd. Pharmaceuticals: OtherHealth Technology Operates as a clinical-stage pharmaceutical company that develops cannabis-based therapies for use as medical cannabis products | Health Technology |
Novartis Oncology | |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Noon Aesthetics Ltd.
Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Manufactures skin care products | Consumer Non-Durables |
